chs-114
Generic: anti-CCR8 antibody·Code: SRF114
chs-114: developed by 2 companies · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (2)
| Company | Phase |
|---|---|
| Coherus Oncology, Inc. (CHRS) | Phase 1 |
| VACCINEX, INC. (VCNX) | Phase 1 |
Clinical Trials (1)
A Phase 1 Study of CHS-114 in Participants With Advanced Solid Tumors
Frequently asked questions
Who is developing chs-114?
chs-114 is being developed by Coherus Oncology, Inc., VACCINEX, INC..
How many clinical trials involve chs-114?
BioSniper tracks 1 clinical trial involving chs-114.
Get deeper analysis on chs-114
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis